Tiagabine

In the US, Tiagabine (tiagabine systemic) is a member of the drug class gamma-aminobutyric acid reuptake inhibitors and is used to treat Seizures.

US matches:

• Tiagabine


• Tiagabine Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N03AG06

CAS registry number (Chemical Abstracts Service)

0115103-54-3

Chemical Formula

C20-H25-N-O2-S2

Molecular Weight

375

Therapeutic Category

Antiepileptic agent

Chemical Name

(-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid

Foreign Names

• Tiagabinum (Latin)
• Tiagabin (German)
• Tiagabine (French)
• Tiagabina (Spanish)

Generic Names

• Tiagabine (OS: DCF, BAN)
• N 05-0328 (IS: NovoNordisk)
• NNC 05-0328 (IS)
• NO 328 (IS)
• Tiagabine Hydrochloride (OS: BANM, USAN)
• Abbott 70569 (IS: Abbott)
• ABT 569 (IS: Abbott)
• Tiagabine Hydrochloride (PH: USP 32)

Brand Names

• Gabitril
  Cephalon, Ireland; Cephalon, Iceland; Cephalon, Italy; Lafon, Luxembourg; Sanofi-Aventis, Poland; Taiwan Biotech, Taiwan; Cephalon, Belgium; Cephalon, Germany; Cephalon, Finland; Cephalon, France; Cephalon, United Kingdom; Cephalon, United States; Cephalon Pharma, Denmark; Globopharm, Switzerland; ITF, Portugal; Noventure, Spain; Orphan, Australia; png Gerolymatos, Greece; Sanofi-Aventis, Belgium; Torrex, Bulgaria; Torrex, Czech Republic; Torrex, Latvia; Torrex, Slovenia; Torrex, Slovakia; Torrex Chiesi, Lithuania

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.